Peripheral Artery Disease (PAD): Symptoms, Causes, Treatment & Nursing Care

Peripheral artery disease (PAD) is chronic obstructive atherosclerosis of the non-coronary arterial tree that supplies the lower limbs. Inflammatory lipid plaque accumulates at points of turbulent flow—typically the superficial femoral artery at the adductor hiatus, tibial bifurcations and previously injured endothelium—until luminal narrowing reduces distal perfusion during exertion and, when critical, at rest. Vascular remodelling and collateral formation partly compensate, which explains why identical angiographic grades produce different walk distances from patient to patient.

The pathophysiology is inseparable from systemic atherosclerosis: most adults with PAD harbour occult coronary or cerebrovascular plaque, so leg symptoms are only the visible edge of endothelial dysfunction, dyslipidaemia and smoking-related injury. Type 2 diabetes accelerates medial calcification and microcirculatory shunting, which distorts ABI and masks severity until tissue loss appears.

Nursing reasoning therefore extends beyond “can they walk?” to whether cardiovascular prevention is optimised, ulcers are probed for depth and infection, and objective perfusion numbers are interpreted alongside pulse palpation—especially when the patient minimises symptoms because they have adapted daily activity.

Typical exertional ischaemia

Classic claudication is a reproducible cramp, ache or fatigue in the calf, thigh or buttock that appears after a fairly stable walking distance on level ground and eases within minutes of rest. Patients may subconsciously limit mileage (“I just don’t walk far”), so directly ask about baseline versus prior function. Leg pain that is unrelated to effort or that persists lying flat suggests alternative diagnoses.

Atypical and “silent” presentations

• Isolated foot pallor on standing, slow toe capillary return or hair loss without overt cramps—particularly in type 2 diabetes where neuropathy blunts ischaemic pain.
• Early fatigue without frank pain; older adults may attribute symptoms to arthritis until duplex ultrasound proves flow limitation.
• Rest pain classically worsens with limb elevation and improves dangling; patients may sleep in a chair.

Chronic limb-threatening ischaemia (CLI)

Rest pain, non-healing toe or heel ulcers beyond six weeks, or dry/wet gangrene indicate CLI and mandate urgent vascular multidisciplinary care. Fever or spreading erythema superimposed on an ischaemic ulcer usually mixes arterial insufficiency with cellulitis and raises amputation and sepsis stakes.

Over 90% of PAD is atherosclerotic; rare alternatives include Takayasu or giant-cell arteritis, thromboangiiitis obliterans (Buerger), popliteal entrapment, cystic adventitial disease and trauma. Bedside history should still screen for thromboembolism, especially with abrupt symptoms and atrial fibrillation.

Non-modifiable

• Increasing age and male sex (though female sex loses protection after diabetes or smoking).
• Family history of early cardiovascular events.
• Prior coronary or cerebrovascular disease—signals pan-arterial plaque burden.

Modifiable

• Cigarette smoking—the single strongest population-attributable factor for claudication progression.
• Diabetes, hypertension and chronic kidney disease promote calcification and endothelial injury.
• Sedentary pattern and poorly controlled lipids accelerate functional decline once claudication starts.

When any feature above appears, avoid reassurance tropes; document neurovascular status hourly, keep the limb neither excessively elevated nor dependent without orders, and prepare for possible imaging or theatre.

Clinical assessment

Map QUALITY of pain, aggravating factors and limb dependence; inspect skin temperature, muscle bulk and shoe pressure points; palpate femoral, popliteal, dorsalis pedis and posterior tibial pulses—but remember diabetes may preserve misleading pedal pulses through stiff vessels. Listen for femoral bruits; history of transient ischaemic symptoms may prompt carotid duplex per stroke pathway.

Laboratory investigations

• Fasting lipids, HbA1c, renal function—inform statin intensity and contrast choices.
• FBC and inflammatory markers when tissue loss or infection is present.

Physiological and imaging studies

• ABI: ratio of systolic pressure at each ankle to brachial systolic; ≤0.90 supports PAD; borderline 0.91–0.99 merits exercise testing where available.
• Toe pressures / TBI: essential when ABI >1.40 (non-compressible) or in advanced diabetes.
• Duplex ultrasound: localises lesion level, peak velocities and occlusion length before revascularisation.
• CTA/MRA reserved for planning when invasive therapy is likely; digital subtraction angiography intra-procedure.

Severity frameworks (ward communication aid)

↔Swipe on small screens to view the full table.

1. Suspect PAD with exertional leg symptoms, reduced pulses, known atherosclerosis or diabetes mellitus.
2. Obtain resting ABI ± toe pressures; if normal but suspicion remains high, arrange exercise ABI or vascular lab review.
3. If ABI confirms PAD and claudication limits QoL, initiate supervised exercise, high-intensity statin, antiplatelet therapy for symptomatic disease, blood pressure and glucose control, smoking cessation counselling.
4. Progressive symptoms, CLI features or failure of conservative care triggers duplex and vascular referral for revascularisation candidacy.
5. Document infection, neuropathy and perfusion at every wound review; escalate same day when ulcers deepen or systemic features emerge.

• Neurogenic claudication from lumbar spinal stenosis—often bilateral, bicycle test may differ, ABI often normal.
• Venous insufficiency—aching with dependency, oedema, hemosiderin staining; ABIs typically normal.
• DVT / phlegmasia—acute swelling, venous duplex key.
• Musculoskeletal strain, Baker cyst, hip arthritis—pain pattern not exertion-limited in the same way.
• Sympathetic / CRPS pain—disproportionate allodynia without objective flow loss.

First-line medical and lifestyle care

• Smoking cessation with pharmacotherapy per local protocol—single highest yield intervention.
• High-intensity statin unless contraindicated—titrate to tolerance with hepatic and muscle safety labs per prescriber.
• Antiplatelet therapy for symptomatic PAD per regional guideline (commonly aspirin or clopidogrel); record bleeding risk and interactions.
• Supervised exercise therapy—structured walking to claudication threshold three-to-five times weekly for ≈12 weeks.
• Blood-pressure and glycaemic control aligned with cardiovascular risk; teach foot protection in diabetes.

Second-line pharmacologic

• Cilostazol for claudication when heart failure absent—monitor headache, palpitations and bleeding with other agents.
• Pentoxifylline remains a weaker adjunct in some regions when cilostazol unsuitable.

Revascularisation

Endovascular angioplasty ± stent, bypass or hybrid strategies are selected by lesion morphology, distal runoff, comorbidity and frailty. Nurses anchor pre-procedure NPO rules, contrast-induced nephropathy prevention bundles, groin or radial puncture observation, and post-reperfusion compartment awareness.

Special populations

• Advanced CKD: minimise nephrotoxic contrast load; coordinate with renal teams.
• Frail older adults: weigh functional gain versus procedural risk; falls and cognition affect adherence.

• Re-check bilateral brachial blood pressures once per visit when PAD is new—subclavian or brachial gradients occasionally surface.
• Repeat ABI after major cardiovascular events, new ulcers or six months post-revascularisation unless vascular specifies otherwise.
• Supervised exercise programmes: verify attendance, resting pain, chest symptoms and hypoglycaemia precautions in insulin users.
• Polypharmacy: run interaction checks between antiplatelet, novel anticoagulant trials pathways and NSAIDs—bleeding can erase limb perfusion gains.
• Refer early to podiatry when callus, nail pathology or fungal infection threatens skin envelope integrity.
• Treatment “failure” is new rest pain, declining walk distance despite adherence, or non-healing wounds after eight to twelve weeks—bump to vascular MDT without delaying.

• Acute limb ischaemia, subacute stent thrombosis or bypass graft occlusion.
• Chronic ulcers progressing to osteomyelitis, sepsis or major amputation.
• Myocardial infarction, stroke and cardiovascular death from untreated systemic plaque.
• Contrast-induced kidney injury and access-site pseudoaneurysm after endovascular procedures.

Clinician-facing prevention centres on smoking abstinence, lipid and BP targets, foot surveillance in diabetes, and prompt ABI screening when walk distance falls. Cardiac rehabilitation models often accommodate PAD patients—link referrals instead of siloing “leg” and “heart” education.

Asymptomatic PAD still elevates five-year cardiovascular mortality; claudication stabilises in many patients with therapy, while roughly one quarter worsen functionally without revascularisation. CLI carries substantial one-year amputation and death risk, underscoring why nursing documentation of subtle perfusion change matters. Honest counselling pairs hope (exercise works) with urgency (new night pain is not normal ageing).

Patients may normalise limited mobility or fear amputation so deeply they under-report pain—use objective repeat walk tests when safe. Interpreter access matters when discussing smoking or procedural consent. Rehearse red-flag language (“If the foot turns blue or you cannot bear weight, call emergency services”) in the patient’s own words. Offloading for ischaemic ulcers should never rely on adhesive dressings that tear fragile skin; photograph lesions at identical angles for remote vascular review.

• Both-brachial and symptom-limited limb blood pressures when ordered; document cuff size and limb.
• Skin temperature, colour, capillary return and peripheral pulses each shift for inpatient CLI or post-revascularisation patients.
• Wound dimensions, odour, undermining and pain score—trend beats single snapshots.
• Telemetry or ECG surveillance when cilostazol or electrolyte shifts complicate post-contrast recovery.

Activate rapid response per local policy, keep lines available for resuscitation, mark demarcation of colour change with time, and communicate anticipated vascular contact window clearly at handover.

Nursing-priority lens (NCSBN Clinical Judgment Measurement Model): recognise cues → analyse cues → prioritise hypotheses → generate solutions → take safe action → evaluate outcomes. These NCLEX-style clinical judgment practice items mix prioritisation, multi-select analysis, deterioration recognition, triage, sequencing, matrix decisions and cloze completion around ABI interpretation, medical therapy, exercise therapy and limb-threat escalation.